Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

Edelman extends PR contract with Leo Pharma

Will continue to work together in Germany

- PMLiVE

Translational pharmacology: the key to ensuring safe and effective dosing

Designing pharmacokinetic and toxicokinetic studies during preclinical and early phase 1 trials will maximise a candidate’s chance of safety and efficacy success

Vansen Pharma appoints new president and CEO

Ahmad Doroudian was CEO of Merus Labs International

Biogen Idec building

Eisai and Biogen partner on Alzheimer’s

Will co-develop two drug candidates

- PMLiVE

Generic for Lilly’s Evista in US ‘within a month’

Teva to launch copy of osteoporosis drug

- PMLiVE

NICE relents and backs Pfizer’s Inlyta

Recommends drug to treat advanced kidney cancer on NHS in England

- PMLiVE

Novasep appoints board chairman

CEO Michel Spagnol takes on dual role

- PMLiVE

Compulsory evaluation in France

French authorities will expect robust health economic cases to be made for some drugs

- PMLiVE

NHS promotes better drug understanding

‘My Medicines, My Health’ kicks off in north east England

KCR expanding into the UK and Germany

Contract research organisation registers two new entities

Teva Pharma logo

Teva launches first inhaled antipsychotic in US

Adasuve available for the treatment of agitation associated with schizophrenia or bipolar disorder

National Institute for Health and Care Excellence NICE logo

NICE: Alexion must justify Soliris’ high cost

UK body unable to recommend ‘ultra-orphan’ drug

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links